IBDEI370 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,50976,1,4,0)
 ;;=4^A60.01
 ;;^UTILITY(U,$J,358.3,50976,2)
 ;;=^5000353
 ;;^UTILITY(U,$J,358.3,50977,0)
 ;;=B00.1^^193^2499^33
 ;;^UTILITY(U,$J,358.3,50977,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50977,1,3,0)
 ;;=3^Herpesviral Vesicular Dermatitis
 ;;^UTILITY(U,$J,358.3,50977,1,4,0)
 ;;=4^B00.1
 ;;^UTILITY(U,$J,358.3,50977,2)
 ;;=^5000468
 ;;^UTILITY(U,$J,358.3,50978,0)
 ;;=B97.89^^193^2499^89
 ;;^UTILITY(U,$J,358.3,50978,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50978,1,3,0)
 ;;=3^Viral Agent Cause of Disease
 ;;^UTILITY(U,$J,358.3,50978,1,4,0)
 ;;=4^B97.89
 ;;^UTILITY(U,$J,358.3,50978,2)
 ;;=^5000879
 ;;^UTILITY(U,$J,358.3,50979,0)
 ;;=B97.10^^193^2499^21
 ;;^UTILITY(U,$J,358.3,50979,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50979,1,3,0)
 ;;=3^Enterovirus Cause of Disease
 ;;^UTILITY(U,$J,358.3,50979,1,4,0)
 ;;=4^B97.10
 ;;^UTILITY(U,$J,358.3,50979,2)
 ;;=^5000861
 ;;^UTILITY(U,$J,358.3,50980,0)
 ;;=B34.9^^193^2499^90
 ;;^UTILITY(U,$J,358.3,50980,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50980,1,3,0)
 ;;=3^Viral Infection,Unspec
 ;;^UTILITY(U,$J,358.3,50980,1,4,0)
 ;;=4^B34.9
 ;;^UTILITY(U,$J,358.3,50980,2)
 ;;=^5000603
 ;;^UTILITY(U,$J,358.3,50981,0)
 ;;=A69.20^^193^2499^50
 ;;^UTILITY(U,$J,358.3,50981,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50981,1,3,0)
 ;;=3^Lyme Disease,Unspec
 ;;^UTILITY(U,$J,358.3,50981,1,4,0)
 ;;=4^A69.20
 ;;^UTILITY(U,$J,358.3,50981,2)
 ;;=^5000375
 ;;^UTILITY(U,$J,358.3,50982,0)
 ;;=A69.22^^193^2499^52
 ;;^UTILITY(U,$J,358.3,50982,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50982,1,3,0)
 ;;=3^Neurologic Disorders d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,50982,1,4,0)
 ;;=4^A69.22
 ;;^UTILITY(U,$J,358.3,50982,2)
 ;;=^5000377
 ;;^UTILITY(U,$J,358.3,50983,0)
 ;;=A69.21^^193^2499^51
 ;;^UTILITY(U,$J,358.3,50983,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50983,1,3,0)
 ;;=3^Meningitis d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,50983,1,4,0)
 ;;=4^A69.21
 ;;^UTILITY(U,$J,358.3,50983,2)
 ;;=^5000376
 ;;^UTILITY(U,$J,358.3,50984,0)
 ;;=A69.29^^193^2499^18
 ;;^UTILITY(U,$J,358.3,50984,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50984,1,3,0)
 ;;=3^Conditions d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,50984,1,4,0)
 ;;=4^A69.29
 ;;^UTILITY(U,$J,358.3,50984,2)
 ;;=^5000379
 ;;^UTILITY(U,$J,358.3,50985,0)
 ;;=A69.23^^193^2499^5
 ;;^UTILITY(U,$J,358.3,50985,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50985,1,3,0)
 ;;=3^Arthritis d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,50985,1,4,0)
 ;;=4^A69.23
 ;;^UTILITY(U,$J,358.3,50985,2)
 ;;=^5000378
 ;;^UTILITY(U,$J,358.3,50986,0)
 ;;=A51.0^^193^2499^29
 ;;^UTILITY(U,$J,358.3,50986,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50986,1,3,0)
 ;;=3^Genital Syphilis,Primary
 ;;^UTILITY(U,$J,358.3,50986,1,4,0)
 ;;=4^A51.0
 ;;^UTILITY(U,$J,358.3,50986,2)
 ;;=^5000272
 ;;^UTILITY(U,$J,358.3,50987,0)
 ;;=A52.3^^193^2499^54
 ;;^UTILITY(U,$J,358.3,50987,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50987,1,3,0)
 ;;=3^Neurosyphilis,Unspec
 ;;^UTILITY(U,$J,358.3,50987,1,4,0)
 ;;=4^A52.3
 ;;^UTILITY(U,$J,358.3,50987,2)
 ;;=^5000298
 ;;^UTILITY(U,$J,358.3,50988,0)
 ;;=A52.10^^193^2499^53
 ;;^UTILITY(U,$J,358.3,50988,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50988,1,3,0)
 ;;=3^Neurosyphilis Symptomatic,Unspec
 ;;^UTILITY(U,$J,358.3,50988,1,4,0)
 ;;=4^A52.10
 ;;^UTILITY(U,$J,358.3,50988,2)
 ;;=^5000291
 ;;^UTILITY(U,$J,358.3,50989,0)
 ;;=A52.9^^193^2499^49
